Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 4
1993 3
1995 3
1996 3
1997 5
1998 6
1999 3
2000 7
2001 3
2002 2
2003 3
2004 5
2005 9
2006 2
2007 4
2008 5
2009 7
2010 10
2011 3
2012 3
2013 2
2014 4
2015 4
2016 3
2017 5
2018 3
2019 5
2020 6
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

118 results
Results by year
Filters applied: . Clear all
Page 1
A Unique Morphological Phenotype in Chemoresistant Triple-Negative Breast Cancer Reveals Metabolic Reprogramming and PLIN4 Expression as a Molecular Vulnerability.
Sirois I, Aguilar-Mahecha A, Lafleur J, Fowler E, Vu V, Scriver M, Buchanan M, Chabot C, Ramanathan A, Balachandran B, Légaré S, Przybytkowski E, Lan C, Krzemien U, Cavallone L, Aleynikova O, Ferrario C, Guilbert MC, Benlimame N, Saad A, Alaoui-Jamali M, Saragovi HU, Josephy S, O'Flanagan C, Hursting SD, Richard VR, Zahedi RP, Borchers CH, Bareke E, Nabavi S, Tonellato P, Roy JA, Robidoux A, Marcus EA, Mihalcioiu C, Majewski J, Basik M. Sirois I, et al. Among authors: saragovi hu. Mol Cancer Res. 2019 Dec;17(12):2492-2507. doi: 10.1158/1541-7786.MCR-19-0264. Epub 2019 Sep 19. Mol Cancer Res. 2019. PMID: 31537618 Free article.
Novel approaches for targeted cancer therapy.
Guillemard V, Saragovi HU. Guillemard V, et al. Among authors: saragovi hu. Curr Cancer Drug Targets. 2004 Jun;4(4):313-26. doi: 10.2174/1568009043332989. Curr Cancer Drug Targets. 2004. PMID: 15180497 Review.
118 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page